Loading institutional data...
Loading institutional data...
Held by 175 of 5,944 reporting institutions (91th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94.6M 100.0% | $138.7M 100.0% | $139.9M 100.0% | $110.8M 100.0% | $133.7M 100.0% | $125.0M 100.0% | $26.7M 100.0% | $477.1M 100.0% | $12.3M 100.0% | $15.0M 100.0% |
| Cost of Revenue | $29.7M 31.4% | $31.3M 22.6% | $17.8M 12.7% | $10.4M 9.4% | $16.6M 12.4% | $14.8M 11.8% | $1.8M 6.7% | $95.3M 20.0% | $0 0.0% | $0 0.0% |
| Research & Development | $20.0M 21.1% | $12.3M 8.9% | $16.4M 11.7% | $22.5M 20.3% | $9.9M 7.4% | $10.9M 8.8% | $13.3M 49.7% | $13.0M 2.7% | $16.7M 136.0% | $19.7M 131.5% |
| Selling, General & Admin | $21.2M 22.4% | $25.1M 18.1% | $22.0M 15.8% | $35.1M 31.7% | $18.0M 13.5% | $14.7M 11.8% | $13.3M 49.6% | $12.9M 2.7% | $12.3M 100.3% | $13.7M 91.5% |
| Total Operating Expenses | $70.9M 74.9% | $68.7M 49.6% | $56.3M 40.2% | $68.1M 61.5% | $44.6M 33.3% | $40.5M 32.4% | $29.1M 108.7% | $122.0M 25.6% | $31.1M 253.6% | $46.0M 306.9% |
| Operating Income | $23.7M 25.1% | $70.0M 50.4% | $83.6M 59.8% | $42.7M 38.5% | $89.1M 66.7% | $84.5M 67.6% | -$2.3M -8.7% | $355.1M 74.4% | -$18.8M -153.6% | -$31.0M -206.9% |
| Interest Expense | — | — | — | $0 0.0% | $0 0.0% | $3.0M 2.4% | $15.8M 59.0% | $15.5M 3.2% | $14.8M 120.3% | $2.4M 16.0% |
| Other Income (Expense), net | $6.7M 7.1% | $6.1M 4.4% | $4.2M 3.0% | $1.0M 0.9% | $101K 0.1% | $532K 0.4% | $2.8M 10.6% | $78.9M 16.5% | $17K 0.1% | $102K 0.7% |
| Pretax Income | $30.4M 32.1% | $76.1M 54.8% | $87.8M 62.7% | $44.1M 39.8% | $89.3M 66.8% | $73.5M 58.8% | -$10.2M -38.1% | $411.6M 86.3% | -$38.3M -312.4% | -$39.7M -264.8% |
| Income Tax Expense | $7.1M 7.5% | $16.9M 12.2% | $19.7M 14.1% | $10.2M 9.2% | $19.9M 14.9% | $17.2M 13.7% | -$2.9M -11.0% | -$10.2M -2.1% | -$2.1M -17.1% | $14K 0.1% |
| Net Income | $23.3M 24.6% | $59.2M 42.7% | $68.1M 48.6% | $33.9M 30.6% | $69.5M 52.0% | $56.3M 45.1% | -$7.2M -27.1% | $421.8M 88.4% | -$36.2M -295.3% | -$39.7M -264.9% |
| Per Share | ||||||||||
| EPS (Basic) | $0.33 | $0.83 | $0.95 | $0.46 | $0.92 | $0.71 | $-0.09 | $5.28 | $-0.46 | $-0.69 |
| EPS (Diluted) | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 | $0.71 | $-0.15 | $5.18 | $-0.46 | $-0.69 |
| Weighted Avg Shares (Basic) | 71.5M | 71.3M | 71.4M | 72.9M | 75.3M | 79.3M | 81.0M | 79.9M | 78.9M | 57.2M |
| Weighted Avg Shares (Diluted) | 71.9M | 71.9M | 71.7M | 73.5M | 76.4M | 79.4M | 82.2M | 82.7M | 78.9M | 57.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $43M dividends + $0 buybacks = $43M returned.
2 consecutive years of dividend increases · 10%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 12%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $155M covers all $5M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2012-12-31 (10-K/A).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Interest last disclosed in FY2020 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 1111 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | $1.05T | 51.0× | — | 16.1× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $679.0B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $620.1B | 23.4× | — | 6.6× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $435.4B | 104.3× | 31.4× | 7.1× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| UNH | $374.0B | 31.2× | 21.4× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| BDRX | $359.1B | — | — | — | — | — | — | — | — | — | 7 |
| MRK | $321.1B | 17.6× | — | 4.9× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| NVSEF | $289.9B | — | — | — | — | — | — | — | — | — | 2 |
| AZN | $250.4B | — | — | — | — | — | — | — | — | — | 1,248 |
| AMGN | $219.7B | 28.7× | 18.3× | 6.0× | 10.0% | 67.2% | 21.0% | 89.1% | 13.1% | 3.5× | 3,014 |
| TMO | $217.8B | 32.6× | 28.5× | 4.9× | 3.9% | — | 15.1% | 12.6% | 7.0% | 4.9× | 2,481 |
| ABT | $183.9B | 28.4× | 19.5× | 4.2× | 5.7% | 56.4% | 14.7% | 12.5% | 10.5% | 1.0× | 2,964 |
| GILD | $163.5B | 19.4× | 18.1× | 5.5× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| PFE | $146.7B | 19.0× | — | 2.3× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $141.1B | 39.5× | 29.3× | 5.7× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $133.2B | 47.7× | 36.6× | 13.2× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| SYK | $128.8B | 40.1× | 21.8× | 5.1× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| CVS | $126.0B | 71.3× | 12.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| VRTX | $123.1B | 31.6× | 26.9× | 10.3× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| MDT | $110.1B | 23.1× | 11.7× | 3.0× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| GLAXF | $106.9B | — | — | — | — | — | — | — | — | — | 5 |
| MCK | $102.7B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| SNYNF | $101.3B | — | — | — | — | — | — | — | — | — | 5 |
| HCA | $92.0B | 14.5× | — | 1.2× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $86.4B | 15.5× | 14.8× | 0.4× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| SIGA | $226M | 9.8× | 2.9× | 2.4× | -31.8% | 68.6% | 24.6% | 11.7% | 11.7% | — | 175 |
Peers = companies sharing SIGA's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
No material risks flagged.
Where each multiple sits in its own 14-yr range · 40th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 20.0 | 6.7 | 11.8 | 12.4 | 9.4 | 12.7 | 22.6 | 31.4 |
| R&D | 2.7 | 49.7 | 8.8 | 7.4 | 20.3 | 11.7 | 8.9 | 21.1 |
| SG&A | 2.7 | 49.6 | 11.8 | 13.5 | 31.7 | 15.8 | 18.1 | 22.4 |
| Operating Income | 74.4 | -8.7 | 67.6 | 66.7 | 38.5 | 59.8 | 50.4 | 25.1 |
| Income Tax | -2.1 | -11.0 | 13.7 | 14.9 | 9.2 | 14.1 | 12.2 | 7.5 |
| Net Income | 88.4 | -27.1 | 45.1 | 52.0 | 30.6 | 48.6 | 42.7 | 24.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SIGA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.